Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug;23(8):383-94.
doi: 10.1097/FPC.0b013e32833d7b45.

Genome-wide association studies in pharmacogenomics: successes and lessons

Alison A Motsinger-Reif  1 , Eric Jorgenson, Mary V Relling, Deanna L Kroetz, Richard Weinshilboum, Nancy J Cox, Dan M Roden
Affiliations
Review

Genome-wide association studies in pharmacogenomics: successes and lessons

Alison A Motsinger-Reif et al. Pharmacogenet Genomics. 2013 Aug.

Abstract

Objective: As genotyping technology has progressed, genome-wide association studies (GWAS) have matured into efficient and effective tools for mapping genes underlying human phenotypes.

Methods: Recent studies have shown the utility of the GWAS approach for examining pharmacogenomic traits, including drug metabolism, efficacy, and toxicity.

Results: Application of GWAS to pharmacogenomic outcomes presents unique challenges and opportunities.

Conclusion: In the current review, we discuss the potential promises and potential caveats of this approach specifically as it relates to pharmacogenomic studies. Concerns with study design, power and sample size, and analysis are reviewed. We further examine the features of successful pharmacogenomic GWAS, and describe consortia efforts that are likely to expand the reach of pharmacogenomic GWAS in the future.

PubMed Disclaimer

References

    1. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009;106(23):9362–9367. - PMC - PubMed
    1. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9(5):356–369. - PubMed
    1. Weinshilboum R, Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov. 2004;3(9):739–748. - PubMed
    1. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6(2):95–108. - PubMed
    1. Roden DM, Altman RB, Benowitz NL, Flockhart DA, Giacomini KM, Johnson JA, Krauss RM, McLeod HL, Ratain MJ, Relling MV, et al. Pharmacogenomics: challenges and opportunities. Ann Intern Med. 2006;145(10):749–757. - PMC - PubMed

Publication types